Science Exchange, a Palo Alto, CA-based provider of life sciences procurement and supplier management SaaS solutions, today announced its acquisition by Waud Capital Partners.
The amount of the deal was not disclosed.
The partnership with Waud Capital will enable the company to invest in technologies, and elevate its market presence.
Led by Elizabeth Iorns, Ph.D., and CEO, Science Exchange is a provider of a procurement and supplier orchestration cloud software platform for life sciences companies. The platform digitizes procurement workflows, including initial supplier and product discovery, contracting and compliance management, RFP management, purchase and change orders, internal approvals, spend and pricing intelligence, and invoicing and payment. The solution has gained traction among the scientists and procurement teams of top global pharmaceutical companies and biotech organizations as it drives substantial cost savings, streamlines supplier collaboration, and accelerates project execution.
Elizabeth Iorns, Ph.D, CEO & Co-Founder, along with Dan Knox, COO & Co-Founder, and Tzlil Hadass, Chief Revenue Officer, will retain their leadership roles, ensuring continuity for customers and stakeholders.
Mark Layden, Operating Partner at Waud Capital, will join the company as Executive Chairman.
FinSMEs
01/10/2024